Analysts Are Downgrading These 5 Pharmaceutical Stocks
In this article, we present the 5 pharmaceutical stocks that are being downgraded by analysts.
Checkmate Pharmaceuticals Inc. (CMPI)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Clough Capital Partners Charles Clough | 0 | $0 | 0% | |
| 2. | Sectoral Asset Management Jerome Pfund And Michael Sjostrom | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.04 | 7,224 | Officer | 815,734 | 2021-06-18 | Filing | |
| $6.18 | 3,578 | Officer | 808,510 | 2021-06-16 | Filing | |
| $6.97 | 25,001 | Officer | 804,932 | 2021-05-18 | Filing | |
| $12.15 | 3,484 | Officer | 746,711 | 2021-03-26 | Filing | |
| $12.35 | 10,036 | Officer | 743,227 | 2021-03-25 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.45 | 95,800 | Large Shareholder | 2,155,930 | 2022-05-16 | Filing | |
| $10.45 | 35,850 | Large Shareholder | 2,251,730 | 2022-05-13 | Filing | |
| $10.39 | 124,525 | Large Shareholder | 2,287,580 | 2022-05-12 | Filing | |
| $10.38 | 17,700 | Large Shareholder | 2,412,105 | 2022-05-11 | Filing | |
| $10.38 | 18,676 | Large Shareholder | 2,429,805 | 2022-05-10 | Filing |
Institutional Investors' Holdings
News See All
Hedge Fund and Insider Trading News: James Woodson Davis, Michael Novogratz, Farallon Capital Management, Twilio Inc (TWLO), HIVE Blockchain Technologies Ltd (HVBTF), and More
For little-known hedge-fund manager Jim Davis, 2020 is a career-defining year. The one-time analyst for famed hedge-fund manager Julian Robertson Jr.
Is Checkmate Pharmaceuticals (CMPI) A Good Stock To Buy Now?
In this article we will check out the progression of hedge fund sentiment towards Checkmate Pharmaceuticals, Inc. (NASDAQ:CMPI) and determine whether it is a good investment right now.
Billionaire Hedge Funds
